Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1999
11/18/1999WO1999051202A3 Quinolone containing liposomes and their use as antibacterial agents
11/18/1999WO1999051192A3 Low residue cosmetic composition
11/18/1999WO1999049909A3 Revascularization apparatus having coaxial channeling and injecting means
11/18/1999WO1999049846A3 Compositions containing microparticles of water-insoluble substances and method for their preparation
11/18/1999WO1999042134A8 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders
11/18/1999WO1999036099A8 Sustained release compositions, process for producing the same and utilization thereof
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821951A1 Orally administered solid or liquid cyclosporin compositions
11/18/1999DE19821003A1 New dihydro-indazolone derivatives useful as antiasthmatic, antiallergic and neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999DE19821002A1 New indazole derivatives useful as antiasthmatic, antiallergic, neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999DE19820999A1 Layered medicinal adhesive plaster with high holding power and flexibility
11/18/1999CA2332110A1 Biologically active composition
11/18/1999CA2332012A1 Laminate for application onto an acceptor
11/18/1999CA2331871A1 Novel formulation containing paroxetine
11/18/1999CA2331849A1 Novel formulation containing paroxetine
11/18/1999CA2331661A1 Use of 'nanofood' in foodstuff final products for humans and animals
11/18/1999CA2331542A1 Antidepressant therapy
11/18/1999CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999CA2331350A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
11/18/1999CA2330741A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
11/18/1999CA2325636A1 Oral medicinal forms with reproducible release of the active ingr edient gatifloxacin or its pharmaceutically acceptable salts or hydrates
11/17/1999EP0957112A2 Low-substituted hydroxypropyl cellulose and process for producing same
11/17/1999EP0956859A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
11/17/1999EP0956858A1 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
11/17/1999EP0956853A2 Use of nanodispersions in pharmaceutical compositions
11/17/1999EP0956851A1 Use of nanotopes in cosmetic products
11/17/1999EP0956779A1 Foods containing water-insoluble compounds
11/17/1999EP0956303A2 Non-naturally occurring lipoprotein particle
11/17/1999EP0956051A1 Compositions and methods for pulmonary gene delivery
11/17/1999EP0956048A1 Stable compositions containing biologically active components
11/17/1999EP0956035A1 Oral cyclosporin formulations
11/17/1999EP0956034A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
11/17/1999EP0956026A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
11/17/1999EP0956014A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
11/17/1999EP0956010A1 Pharmaceutical microspheres of valproic acid for oral administration
11/17/1999EP0956008A1 Micro-capsule support material
11/17/1999EP0956007A1 Chewing gum containing colloidal bismuth subcitrate
11/17/1999EP0956006A1 Colonic delivery of weak acid drugs
11/17/1999EP0956005A1 Device and method for making a segmented tubular capsule containing a biologically active medium
11/17/1999EP0956004A2 Method for producing shaped and unshaped polyol masses
11/17/1999EP0956003A1 Method for the low-waste manufacture of diskoid moulded bodies containing active ingredients, and transdermal therapeutic systems containing same
11/17/1999EP0956002A1 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes
11/17/1999EP0956001A1 PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT $i(IN VIVO) DELIVERY
11/17/1999EP0956000A1 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
11/17/1999EP0955999A1 Novel liposome complexes for increased systemic delivery
11/17/1999EP0955998A2 Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
11/17/1999EP0955997A1 Compositions for topical use containing polysaccharide sulphates
11/17/1999EP0955983A1 Transdermal/transmucosal patch dispenser
11/17/1999EP0955948A1 Induction of immunological tolerance
11/17/1999EP0656026B1 Polyarylates containing derivatives of the natural amino acid l-tyrosine
11/17/1999EP0641389B1 Reagent compositions for analytical testing
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235599A Biphenyl dicarboxylic acid derivatives and preparation thereof
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/17/1999CN1235547A Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
11/17/1999CN1235544A Controlled release dosage form of R-(Z)-alpha-methoxyimino-alpha-(1-azabicyclo 2,2 oct-c-yl) acetonitrile monohydrochloride
11/17/1999CN1235539A Substituted amylose as matrix for sustained drug release
11/17/1999CN1235519A Chewing gum composition and production thereof
11/17/1999CN1235050A Prescription of Tongluofutanwan as medicine for activating collaterals and rehabilitating paralysis and preparing method thereof
11/17/1999CN1235049A Prescription of Yizhifutanwan for reinforcing wisdom and rehabilitating paralysis and preparing method thereof
11/17/1999CN1235041A Medicinal composition for cancers
11/17/1999CN1235040A Agent for stopping smoking
11/17/1999CN1235034A External-use ointment for pains
11/17/1999CN1235027A Micro-capsuled pheochromocyte of bull adrenal medulla as medicine for curing pains
11/17/1999CN1235026A Preparing method for injection of placenta peptide and products thereof
11/17/1999CN1235019A Paste on acupoint for anti-common cold
11/17/1999CN1235018A Preparation of freeze-dried pantoprazole injection and preparing method thereof
11/17/1999CN1235017A Use of nanodispersions in pharmaceutical end formulations
11/17/1999CN1235015A Use of nanodispersions in cosmetic end formulations
11/17/1999CN1046421C Drug for curing pulmonary tuberculosis
11/17/1999CN1046420C Prescription for external use medicine for curing many kinds of diseases
11/17/1999CN1046418C Spray for burn and scald and preparing method thereof
11/17/1999CN1046416C Instant medicine for chyluria
11/17/1999CN1046414C Gucining ointment for spur and preparing method thereof
11/17/1999CN1046411C Injection for curing psoriasic
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986043 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
11/16/1999US5985941 Blends, homogenizing to form emulsions
11/16/1999US5985889 Dosage forms and method for ameliorating male erectile dysfunction
11/16/1999US5985880 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
11/16/1999US5985868 Methods and compositions for treating androgen-dependant diseases using optically pure R-(-) casodex
11/16/1999US5985860 System for transdermal delivery of pain relieving substances
11/16/1999US5985856 Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985843 Pharmaceutical composition containing sucralfate
11/16/1999US5985841 Deoxyglucopyranoside compounds for inducing/stimulating hair growth and/or retarding hair loss
11/16/1999US5985823 Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
11/16/1999US5985354 Preparation of multiwall polymeric microcapsules from hydrophilic polymers
11/16/1999US5985329 Particulate foods and pharmaceuticals coated with water-soluble hemicellulose
11/16/1999US5985328 Micromachined porous membranes with bulk support
11/16/1999US5985327 Solid medium and method for DNA storage
11/16/1999US5985326 Mixing with solvent; coprecipitation; 2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl) -pyrazino(2',1':6,1)pyrido(3,4-b)indole-1,4-dione
11/16/1999US5985325 Tablet core with overcoating of sucrose, polyvinylpyrrolidone, and microcrystalline cellulose
11/16/1999US5985324 Flow controller configurations for an active agent delivery device
11/16/1999US5985323 Microcrystalline cellulose/alginate wet granulation excipient/binder
11/16/1999US5985322 Enteric administering of pellet with fluoxetine core and hydroxypropylmethyl cellulose acetate succinate layer; side effect reduction
11/16/1999US5985321 Soft gelatin capsule manufacture
11/16/1999US5985320 Drug delivery; medical diagnosis; genetic engineering; administering agent that interacts with cell surface receptors
1 ... 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 ... 2991